Guided Therapeutics (GTHP) News Today $0.14 0.00 (0.00%) As of 05/30/2025 Add Compare Share Share Headlines Stock AnalysisChartEarningsSEC FilingsShort InterestBuy This Stock GTHP Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Guided Therapeutics Receives $100,000 from SMI’s Investment Partners to Continue Commercialization Process of LuViva in ChinaMay 27, 2025 | finance.yahoo.comHAYA Therapeutics Raises $65 Million in Series A Funding to Deliver Precision RNA-Guided Medicines for Chronic and Age-Related DiseasesMay 10, 2025 | morningstar.comGuided Therapeutics Announces Filing of Application for NMPA Approval to Market and Sell LuViva in ChinaOctober 22, 2024 | finance.yahoo.comGuided therapeutics director buys shares worth $150,000October 4, 2024 | investing.comGuided Therapeutics Inc (GTHP)August 21, 2024 | investing.comG1 Therapeutics, Inc. (NASDAQ:GTHX) Q1 2024 Earnings Call TranscriptMay 2, 2024 | msn.comLeading Cervical Cancer Doctors Support Approval of LuViva in China Based on Preliminary Review of Clinical Trial ResultsFebruary 20, 2024 | finance.yahoo.comLeading Cervical Cancer Doctors Support Approval of LuViva in China Based on Preliminary Review of Clinical Trial ResultsFebruary 20, 2024 | businesswire.comGuided Therapeutics IncNovember 20, 2023 | thestreet.comGuided Therapeutics Announces Completion of Clinical Study for Chinese Regulatory ApprovalNovember 20, 2023 | finance.yahoo.comGTHPJuly 18, 2023 | seekingalpha.com'It was a trap': Video shows American volunteer likely killed by guided missile in 'deliberate' Russian attackFebruary 17, 2023 | abcnews.go.comGuided Therapeutics Provides Update of Significant Progress in Chinese Clinical Study for Marketing Approval of the LuViva Advanced Cervical ScanNovember 9, 2022 | finance.yahoo.comGuided Therapeutics Receives Institutional Review Board Approval to Start Clinical Study for FDA Approval of the LuViva® Advanced Cervical ScanJuly 20, 2022 | finance.yahoo.comImpel Pharmaceuticals to Present Trudhesa® Data at the 64th Annual Meeting of the American Headache SocietyJune 9, 2022 | finance.yahoo.comOlive Resource Capital Announces Agreement to Acquire C$2.5M Portfolio of AssetsMay 18, 2022 | stockhouse.comGuided Therapeutics Announces Testing Completion of First 150 Patients in Chinese Clinical Study and Receives Milestone Payment of $177,740March 31, 2022 | finance.yahoo.comGuided Therapeutics Announces Start of Chinese Clinical Trial for Approval to Market and Sell LuViva in ChinaNovember 17, 2021 | finance.yahoo.comGuided Therapeutics Ships LuViva Devices to China for Start of Clinical Trial; Receives Additional $100,000 PaymentOctober 5, 2021 | finance.yahoo.com Get Guided Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for GTHP and its competitors with MarketBeat's FREE daily newsletter. Email Address GTHP Media Mentions By Week GTHP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GTHP News Sentiment▼-0.500.88▲Average Medical News Sentiment GTHP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GTHP Articles This Week▼20▲GTHP Articles Average Week Get Guided Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for GTHP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Safe Pro Group Inc. Common Stock News Today Hyperfine News Today Daxor News Today Titan Medical News Today Spectral AI News Today electroCore News Today Envoy Medical News Today Modular Medical News Today Precision Optics News Today Baird Medical Investment News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:GTHP) was last updated on 6/1/2025 by MarketBeat.com Staff From Our PartnersTrump Just Gave the Green Light to Rewrite Social Security?In a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredBanks aren’t ready for this altcoin—are you?I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredThe “supermetal” that could power AIWhile the headlines focus on AI models and chip speed, Elon Musk is investing in the material side of the stor...True Market Insiders | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredThe Buffett Indicator is screaming, “sell stocks, buy gold”A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guided Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Guided Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GTHP Stock Free GTHP Stock Alerts